{"product_id":"harvard-update-in-hospital-medicine-2024","title":"Harvard Update in Hospital Medicine 2024","description":"\u003cdiv class=\"field__item\"\u003e\n\u003cdiv class=\"paragraph paragraph--type--basic-text paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003ch2\u003eHarvard Update in Hospital Medicine 2024\u003c\/h2\u003e\n\u003ch2\u003eComprehensive updates, advances, and best practices to optimize inpatient care\u003c\/h2\u003e\n\u003cem\u003eUpdate in Hospital Medicine will be held online this year, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies.\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eOVERVIEW\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis 4-day intensive program updates busy practitioners on current best practices in hospital medicine. The curriculum covers over 30 core topics, with an emphasis on practical management of common problems (\u003ca href=\"https:\/\/hospitalmedicine.hmscme.com\/schedule\" rel=\"noopener\" target=\"_blank\"\u003eSee schedule\u003c\/a\u003e):\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"field__item\"\u003e\n\u003cdiv class=\"paragraph paragraph--type--two-column-text paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"two-col-wrap\"\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-column-1 field--type-text-long field--label-hidden field__item\"\u003e\n\u003cul\u003e\n\u003cli\u003eHeart failure\u003c\/li\u003e\n\u003cli\u003eAtrial fibrillation\u003c\/li\u003e\n\u003cli\u003ePregnancy\u003c\/li\u003e\n\u003cli\u003eAcute coronary syndromes\u003c\/li\u003e\n\u003cli\u003eDiabetes\u003c\/li\u003e\n\u003cli\u003ePsychiatric disorders\u003c\/li\u003e\n\u003cli\u003eECG interpretation\u003c\/li\u003e\n\u003cli\u003eRadiology interpretation\u003c\/li\u003e\n\u003cli\u003eLaboratory interpretation\u003c\/li\u003e\n\u003cli\u003eBacteremia\u003c\/li\u003e\n\u003cli\u003eUTI\u003c\/li\u003e\n\u003cli\u003ePneumonia\u003c\/li\u003e\n\u003cli\u003eObesity\u003c\/li\u003e\n\u003cli\u003eCritical care\u003c\/li\u003e\n\u003cli\u003eSkin and soft tissue infections\u003c\/li\u003e\n\u003cli\u003eStroke\/TIA\u003c\/li\u003e\n\u003cli\u003e\u003cem\u003eC. difficile\u003c\/em\u003e\u003c\/li\u003e\n\u003cli\u003eEnd-stage renal disease\u003c\/li\u003e\n\u003cli\u003eAcute kidney injury\u003c\/li\u003e\n\u003cli\u003eHIV\u003c\/li\u003e\n\u003cli\u003eEndocrinology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-column-2 field--type-text-long field--label-hidden field__item\"\u003e\n\u003cul\u003e\n\u003cli\u003eHealth equity\u003c\/li\u003e\n\u003cli\u003eGI bleed\u003c\/li\u003e\n\u003cli\u003eHematology\u003c\/li\u003e\n\u003cli\u003eAllergy\u003c\/li\u003e\n\u003cli\u003eGeriatrics\u003c\/li\u003e\n\u003cli\u003eDelirium\u003c\/li\u003e\n\u003cli\u003ePain and palliative care\u003c\/li\u003e\n\u003cli\u003eAlcohol withdrawal\u003c\/li\u003e\n\u003cli\u003eOpioid use disorder\u003c\/li\u003e\n\u003cli\u003eCOPD\u003c\/li\u003e\n\u003cli\u003ePreoperative evaluation\u003c\/li\u003e\n\u003cli\u003eDermatology\u003c\/li\u003e\n\u003cli\u003eElectrolyte disorders\u003c\/li\u003e\n\u003cli\u003eSyncope\u003c\/li\u003e\n\u003cli\u003eVenous thromboembolism\u003c\/li\u003e\n\u003cli\u003ePancreatobiliary disease\u003c\/li\u003e\n\u003cli\u003eCirrhosis\u003c\/li\u003e\n\u003cli\u003eArtificial intelligence\u003c\/li\u003e\n\u003cli\u003eAntibiotics\u003c\/li\u003e\n\u003cli\u003eGoals of care conversations\u003c\/li\u003e\n\u003cli\u003eTrauma-informed care\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"field__item\"\u003e\n\u003cdiv class=\"paragraph paragraph--type--basic-text paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003cbr\u003e\u003cbr\u003eUsing a case-based format, lecturers distill recent evidence, guidelines, and expert opinion to offer “bottom line” recommendations. Faculty include both hospitalists and specialists, and rank among the best teachers at Harvard Medical School.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e2024 PROGRAM HIGHLIGHTS\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eComprehensive review of inpatient antibiotic therapy\u003c\/li\u003e\n\u003cli\u003eThrombolysis in acute stroke: are we going to need a bigger window?\u003c\/li\u003e\n\u003cli\u003eNew data on optimal treatment duration for skin and soft tissue infections\u003c\/li\u003e\n\u003cli\u003eTreating acute and chronic pain in patients with substance use disorders\u003c\/li\u003e\n\u003cli\u003eLess is more in the long run? DAPT vs. monotherapy in ACS\u003c\/li\u003e\n\u003cli\u003eState-of-the-art management of systolic and diastolic heart failure\u003c\/li\u003e\n\u003cli\u003eOral fecal microbiota therapy: new first-line for \u003cem\u003eC. difficile\u003c\/em\u003e?\u003c\/li\u003e\n\u003cli\u003eThe jury is out: anticoagulation in silent atrial fibrillation with a low CHA2DS2-VASc\u003c\/li\u003e\n\u003cli\u003eDifferentiating skin infections and mimics in hospitalized patients\u003c\/li\u003e\n\u003cli\u003eGLP-1 agonists for weight loss: hot takes for the hospitalist\u003c\/li\u003e\n\u003cli\u003eTrauma-informed care in the hospital\u003c\/li\u003e\n\u003cli\u003eAnti-racism in hospital medicine, from triage to care transitions\u003c\/li\u003e\n\u003cli\u003eCovert hepatic encephalopathy: more common than you think\u003c\/li\u003e\n\u003cli\u003eNew kid on the block: cystatin C for GFR\u003c\/li\u003e\n\u003cli\u003eThrombolytics vs. DAPT for mild strokes: weighing the risks and benefits\u003c\/li\u003e\n\u003cli\u003eBest practices in pharmacotherapy for agitated delirium\u003c\/li\u003e\n\u003cli\u003eInjectable therapy for HIV\u003c\/li\u003e\n\u003cli\u003eHarm reduction: reducing the risk of opiate overdose at discharge\u003c\/li\u003e\n\u003cli\u003eEvolving strategies for hepatorenal syndrome: terlipressin\u003c\/li\u003e\n\u003cli\u003eEliminate drug-resistant infections with this one weird trick\u003c\/li\u003e\n\u003cli\u003eDelirium: an ounce of prevention is worth a pound of cure\u003c\/li\u003e\n\u003cli\u003eBest practices and risk mitigation surrounding patient-directed discharges\u003c\/li\u003e\n\u003cli\u003eDo they really need admission? Identifying the low-risk PE patient\u003c\/li\u003e\n\u003cli\u003eShould you switch anticoagulants in patients with breakthrough strokes?\u003c\/li\u003e\n\u003cli\u003eThe debate continues: cefepime vs. piperacillin-tazobactam for sepsis\u003c\/li\u003e\n\u003cli\u003eAre DOACs the preferred anticoagulant in patients with cancer?\u003c\/li\u003e\n\u003cli\u003eEvidence-based tools for risk stratification in syncope\u003c\/li\u003e\n\u003cli\u003eMicrodosing protocols for buprenorphine induction\u003c\/li\u003e\n\u003cli\u003eEvidence-based strategies for serious illness conversations in the hospital\u003c\/li\u003e\n\u003cli\u003eTo DAPT or not to DAPT: antiplatelet therapy in stroke and TIA\u003c\/li\u003e\n\u003cli\u003eHELLP me: managing medical complications in pregnant and postpartum patients\u003c\/li\u003e\n\u003cli\u003eThe never-ending story: steroids in sepsis\u003c\/li\u003e\n\u003cli\u003eAre GLP-1 agonists and SGLT2 inhibitors kidney-saving medications?\u003c\/li\u003e\n\u003cli\u003eCapacity assessment: can this patient make their own decisions?\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" data-once=\"process-print-button\" id=\"block-hmscme-page-title\"\u003e\n\u003ch1 class=\"page-title\"\u003e\u003cspan class=\"field field--name-title field--type-string field--label-hidden\"\u003e2024 Course Highlights\u003c\/span\u003e\u003c\/h1\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"block block-system block-system-main-block\" id=\"block-hmscme-content\"\u003e\u003carticle class=\"node node--type-page node--view-mode-full\" data-history-node-id=\"14\"\u003e\n\u003cdiv class=\"node__content\"\u003e\n\u003cdiv class=\"field field--name-field-content-options field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"field__item\"\u003e\n\u003cdiv class=\"paragraph paragraph--type--basic-text paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003ch3 class=\"text-align-center\"\u003eThis is the highlights list from the 2024 course.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"field__item\"\u003e\n\u003cdiv class=\"paragraph paragraph--type--basic-text paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003cstrong\u003eALLERGY\/IMMUNOLOGY\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eWhat to do when there is no allergist\u003c\/li\u003e\n\u003cli\u003eHow to resolve inappropriate low-risk penicillin allergy labels\u003c\/li\u003e\n\u003cli\u003eUpdates in anaphylaxis management\u003c\/li\u003e\n\u003cli\u003eThings we do for no reason: steroids for anaphylaxis?\u003c\/li\u003e\n\u003cli\u003eClass action: sorting out the overlap between penicillin and cephalosporins\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eCARDIOVASCULAR\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eLess is more in the long run? DAPT vs. monotherapy in ACS\u003c\/li\u003e\n\u003cli\u003eEnd of an era? Beta-blockers after acute MI\u003c\/li\u003e\n\u003cli\u003eCoronary CTA: as good as cardiac catheterization?\u003c\/li\u003e\n\u003cli\u003eHow low should you go? Hemoglobin targets in acute coronary syndromes\u003c\/li\u003e\n\u003cli\u003eState-of-the-art management of systolic and diastolic heart failure\u003c\/li\u003e\n\u003cli\u003eTitration of GDMT: are we being too wimpy?\u003c\/li\u003e\n\u003cli\u003eMore data to support GLP-1 receptor agonists for obesity-related HFpEF\u003c\/li\u003e\n\u003cli\u003eOvercoming diuretic resistance in heart failure\u003c\/li\u003e\n\u003cli\u003eReducing readmissions for heart failure: best practices in discharge planning\u003c\/li\u003e\n\u003cli\u003eUpdated guidelines on atrial fibrillation management\u003c\/li\u003e\n\u003cli\u003eAvoiding common pitfalls of anticoagulation in atrial fibrillation\u003c\/li\u003e\n\u003cli\u003eRhythm control versus rate control for atrial fibrillation revisited\u003c\/li\u003e\n\u003cli\u003eThe jury is out: anticoagulation in silent atrial fibrillation with a low CHA2DS2-VASc\u003c\/li\u003e\n\u003cli\u003eDrug-drug interactions: DOACs and diltiazem\u003c\/li\u003e\n\u003cli\u003eShould you switch anticoagulants in patients with breakthrough strokes?\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eDERMATOLOGY\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCellulitis: antibiotic dilemmas and when to call dermatology\u003c\/li\u003e\n\u003cli\u003eNew data on optimal treatment duration for skin and soft tissue infections\u003c\/li\u003e\n\u003cli\u003eDRESSed to kill: drug reactions and other can’t-miss dermatology diagnoses\u003c\/li\u003e\n\u003cli\u003eCutaneous findings of systemic disease\u003c\/li\u003e\n\u003cli\u003eDifferentiating skin infections and mimics in hospitalized patients\u003c\/li\u003e\n\u003cli\u003eCellulitis or venous stasis? Demystifying the swollen red leg\u003c\/li\u003e\n\u003cli\u003eA cautionary tale: antibiotics with high risk of dermatologic reactions\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eDIAGNOSTICS\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCan’t-miss ECG diagnoses\u003c\/li\u003e\n\u003cli\u003eRadiology pearls: identifying subtle findings on CXR\u003c\/li\u003e\n\u003cli\u003eRapid-fire review of electrolyte, liver, and hematology cases\u003c\/li\u003e\n\u003cli\u003eContrast or no contrast? Choosing the right imaging protocols\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eENDOCRINE\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDangers of SGLT2 inhibitors: euglycemic DKA and UTIs\u003c\/li\u003e\n\u003cli\u003eGLP-1 agonists for weight loss: hot takes for the hospitalist\u003c\/li\u003e\n\u003cli\u003eChallenging cases in inpatient insulin management\u003c\/li\u003e\n\u003cli\u003eContinuous glucose monitoring in hospitalized patients with diabetes\u003c\/li\u003e\n\u003cli\u003eNew guidelines for the management of hyperglycemia in the hospital\u003c\/li\u003e\n\u003cli\u003eAdrenal insufficiency: whom to treat and how to taper steroids\u003c\/li\u003e\n\u003cli\u003ePitfalls in managing thyroid disease in medically ill patients\u003c\/li\u003e\n\u003cli\u003ePractical approach to adrenal incidentalomas\u003c\/li\u003e\n\u003cli\u003eWhen to worry about pheochromocytoma\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEQUITY\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAnti-racism in hospital medicine, from triage to care transitions\u003c\/li\u003e\n\u003cli\u003eProviding top-notch inpatient care to patients with obesity\u003c\/li\u003e\n\u003cli\u003eTrauma-informed care in the hospital\u003c\/li\u003e\n\u003cli\u003eInequities in organ transplantation in the US\u003c\/li\u003e\n\u003cli\u003eRace-based reference ranges: end of an error\u003c\/li\u003e\n\u003cli\u003eRacial equity and pain management in the hospital\u003c\/li\u003e\n\u003cli\u003eImproving patient outcomes with interpreter services\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eGASTROINTESTINAL\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCovert hepatic encephalopathy: more common than you think\u003c\/li\u003e\n\u003cli\u003eEvolving strategies for hepatorenal syndrome: terlipressin\u003c\/li\u003e\n\u003cli\u003eNew guidelines for spontaneous bacterial peritonitis management and prophylaxis\u003c\/li\u003e\n\u003cli\u003eManaging the cirrhotic patient with bleeding and thrombosis\u003c\/li\u003e\n\u003cli\u003eUpdates on management of upper and lower GI bleeds\u003c\/li\u003e\n\u003cli\u003eOptimal timing of endoscopy in upper GI bleeds\u003c\/li\u003e\n\u003cli\u003eNew risk scores to help manage patients with upper GI bleeds\u003c\/li\u003e\n\u003cli\u003eToo soon? When to resume anticoagulation and antiplatelet agents after a GI bleed\u003c\/li\u003e\n\u003cli\u003eFluid resuscitation in acute pancreatitis: less is more\u003c\/li\u003e\n\u003cli\u003eOptimal timing for intra-abdominal drainage in necrotizing pancreatitis\u003c\/li\u003e\n\u003cli\u003eUrgent and non-urgent indications for ERCP\u003c\/li\u003e\n\u003cli\u003eCurrent approaches to preventing post-ERCP pancreatitis\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eGERIATRICS\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ePreoperative frailty assessment in older adults\u003c\/li\u003e\n\u003cli\u003eDelirium: an ounce of prevention is worth a pound of cure\u003c\/li\u003e\n\u003cli\u003eNon-pharmacologic interventions for delirium prevention\u003c\/li\u003e\n\u003cli\u003eDifficult cases in delirium management\u003c\/li\u003e\n\u003cli\u003eBest practices in pharmacotherapy for agitated delirium\u003c\/li\u003e\n\u003cli\u003eGreater caution with antipsychotics in dementia\u003c\/li\u003e\n\u003cli\u003eLess is more: polypharmacy and deprescribing in older patients\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eHEMATOLOGY\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eManagement of patients with bleeding and thrombosis\u003c\/li\u003e\n\u003cli\u003eDiagnosis and management of hypercoagulable states\u003c\/li\u003e\n\u003cli\u003ePearls for the diagnosis and management of thrombocytopenia\u003c\/li\u003e\n\u003cli\u003eDiagnostic approach to anemia in the hospital\u003c\/li\u003e\n\u003cli\u003eTransfusion thresholds in the hospital: how low should you go?\u003c\/li\u003e\n\u003cli\u003eUpdated venous thromboembolism guidelines\u003c\/li\u003e\n\u003cli\u003eIs it ever OK to stop anticoagulation in unprovoked venous thrombosis?\u003c\/li\u003e\n\u003cli\u003eWhat’s in a name: should we use “provoked” vs. “unprovoked” VTE?\u003c\/li\u003e\n\u003cli\u003eDo they really need admission? Identifying the low-risk PE patient\u003c\/li\u003e\n\u003cli\u003eAre DOACs the preferred anticoagulant in patients with cancer?\u003c\/li\u003e\n\u003cli\u003eMore data on DOACs in patients with obesity and chronic kidney disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eINFECTIOUS DISEASES\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eComprehensive review of inpatient antibiotic therapy\u003c\/li\u003e\n\u003cli\u003eShort-course antibiotics for common infections\u003c\/li\u003e\n\u003cli\u003eThe debate continues: cefepime vs. piperacillin-tazobactam for sepsis\u003c\/li\u003e\n\u003cli\u003ePiperacillin-tazobactam and acute kidney injury: overblown?\u003c\/li\u003e\n\u003cli\u003eInjectable therapy for HIV\u003c\/li\u003e\n\u003cli\u003eWho should we screen for HIV in the inpatient setting?\u003c\/li\u003e\n\u003cli\u003eMirror, mirror, on the wall, what’s the least “C-diffy” antibiotic of all?\u003c\/li\u003e\n\u003cli\u003eDoes vancomycin still work against \u003cem\u003eC. difficile\u003c\/em\u003e?\u003c\/li\u003e\n\u003cli\u003eOral fecal microbiota therapy: new first-line for \u003cem\u003eC. difficile? \u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eFidaxomicin for \u003cem\u003eC difficile\u003c\/em\u003e: is it worth the expense?\u003c\/li\u003e\n\u003cli\u003eEliminate multidrug-resistant infections with this one weird trick\u003c\/li\u003e\n\u003cli\u003eControversies in the management of bacteremia\u003c\/li\u003e\n\u003cli\u003eWhen should we consult ID for bacteremia?\u003c\/li\u003e\n\u003cli\u003eErr on the side of caution: when to switch from IV to PO therapy in bacteremia\u003c\/li\u003e\n\u003cli\u003eBreakthroughs in MRSA therapeutics\u003c\/li\u003e\n\u003cli\u003eWhen should we cover for MRSA pneumonia?\u003c\/li\u003e\n\u003cli\u003eNew treatment options for complicated UTIs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePALLIATIVE CARE\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eEvidence-based strategies for serious illness conversations in the hospital\u003c\/li\u003e\n\u003cli\u003eWhich patients benefit most from palliative care?\u003c\/li\u003e\n\u003cli\u003eBest practices for leading family meetings\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePERIOPERATIVE MEDICINE\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eUpdates on perioperative aspirin, statins, beta blockers, and ACE inhibitors\u003c\/li\u003e\n\u003cli\u003eTo hold or not to hold: understanding the latest on perioperative medication management\u003c\/li\u003e\n\u003cli\u003eGLP-1 management in perioperative settings\u003c\/li\u003e\n\u003cli\u003eThe importance of frailty in assessing perioperative risk\u003c\/li\u003e\n\u003cli\u003eReducing pulmonary risk in perioperative patients\u003c\/li\u003e\n\u003cli\u003ePerioperative anticoagulation: when should patients be bridged?\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePREGNANCY\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eBest practices for hypertension management in pregnancy\u003c\/li\u003e\n\u003cli\u003eBenefits, risks, and contraindications to radiologic studies in pregnant patients\u003c\/li\u003e\n\u003cli\u003eHELLP me: managing medical complications in pregnant and postpartum patients\u003c\/li\u003e\n\u003cli\u003ePeriprocedural management of pregnant patients\u003c\/li\u003e\n\u003cli\u003eTreatment guidelines for UTI in pregnancy\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePSYCHIATRY\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ePearls for managing patients with personality disorders in the hospital\u003c\/li\u003e\n\u003cli\u003eInpatient management of psychiatric medications\u003c\/li\u003e\n\u003cli\u003eDiagnostic yield of neuroimaging for common psychiatric presentations\u003c\/li\u003e\n\u003cli\u003eCapacity assessment: can this patient make their own decisions?\u003c\/li\u003e\n\u003cli\u003eBest practices and risk mitigation for patient-directed discharges\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePULMONARY\/CRITICAL CARE\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eTailored steroid therapy in acute COPD exacerbations\u003c\/li\u003e\n\u003cli\u003ePractical applications of the 2023 GOLD guidelines\u003c\/li\u003e\n\u003cli\u003eShort-course antibiotics in COPD exacerbations\u003c\/li\u003e\n\u003cli\u003eUses and limitations of cardioselective beta-blockade in COPD exacerbations\u003c\/li\u003e\n\u003cli\u003eCurrent recommendations for supplemental and high-flow O2 in critical illness\u003c\/li\u003e\n\u003cli\u003eNew Surviving Sepsis guidelines\u003c\/li\u003e\n\u003cli\u003eThe never-ending story: steroids in sepsis\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eRENAL\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eNew kid on the block: cystatin C for GFR\u003c\/li\u003e\n\u003cli\u003ePreventing the progression of chronic kidney disease: another win for GLP-1 agonists\u003c\/li\u003e\n\u003cli\u003eAre GLP-1 agonists and SGLT2 inhibitors kidney-saving medications?\u003c\/li\u003e\n\u003cli\u003eDiagnostic approach to acute kidney injury\u003c\/li\u003e\n\u003cli\u003eIs acute kidney injury a risk factor for dementia?\u003c\/li\u003e\n\u003cli\u003eNew data: early renal replacement therapy in acute kidney injury\u003c\/li\u003e\n\u003cli\u003eDialysis access: what the hospitalist needs to know\u003c\/li\u003e\n\u003cli\u003ePICC and choose: IV access in ESRD patients\u003c\/li\u003e\n\u003cli\u003eIroning it out: managing anemia in ESRD\u003c\/li\u003e\n\u003cli\u003eBlood pressure management in end-stage renal disease\u003c\/li\u003e\n\u003cli\u003eUpdates on hyperkalemia and hyperphosphatemia management\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eSTROKE\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eApproach to imaging in acute stroke syndromes\u003c\/li\u003e\n\u003cli\u003eUpdates on AHA\/ASA guidelines for stroke management\u003c\/li\u003e\n\u003cli\u003eTo DAPT or not to DAPT: antiplatelet therapy in stroke and TIA\u003c\/li\u003e\n\u003cli\u003eThrombolysis in acute stroke: are we going to need a bigger window?\u003c\/li\u003e\n\u003cli\u003eNew agents for thrombolysis in acute stroke\u003c\/li\u003e\n\u003cli\u003eThrombolytics vs. DAPT for mild strokes: weighing the risks and benefits\u003c\/li\u003e\n\u003cli\u003eThrombectomy for acute stroke: is it underused?\u003c\/li\u003e\n\u003cli\u003eTelestroke: an idea whose time has come?\u003c\/li\u003e\n\u003cli\u003eStaying cryptocurrent on cryptogenic stroke\u003c\/li\u003e\n\u003cli\u003eAvoiding hemorrhagic transformation in stroke: when is it safe to start anticoagulation?\u003c\/li\u003e\n\u003cli\u003eShould you switch anticoagulants in patients with breakthrough strokes?\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cdiv class=\"field__item\"\u003e\n\u003cdiv class=\"paragraph paragraph--type--basic-text paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003cdiv class=\"block block-system block-system-main-block\" id=\"block-hmscme-content\"\u003e\u003carticle class=\"node node--type-page node--view-mode-full\" data-history-node-id=\"14\"\u003e\n\u003cdiv class=\"node__content\"\u003e\n\u003cdiv class=\"field field--name-field-content-options field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"field__item\"\u003e\n\u003cdiv class=\"paragraph paragraph--type--basic-text paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003cstrong\u003eSUBSTANCE USE DISORDERS \u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eTreating acute and chronic pain in patients with substance use disorders\u003c\/li\u003e\n\u003cli\u003eManagement of complicated alcohol withdrawal\u003c\/li\u003e\n\u003cli\u003eUpdates on phenobarbital for alcohol withdrawal management\u003c\/li\u003e\n\u003cli\u003eMedication management for alcohol use disorder at discharge\u003c\/li\u003e\n\u003cli\u003eMicrodosing protocols for buprenorphine induction\u003c\/li\u003e\n\u003cli\u003eHarm reduction: reducing the risk of opiate overdose at discharge\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cdiv class=\"field__item\"\u003e\n\u003cdiv class=\"paragraph paragraph--type--basic-text paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003cdiv class=\"block block-system block-system-main-block\" id=\"block-hmscme-content\"\u003e\u003carticle class=\"node node--type-page node--view-mode-full\" data-history-node-id=\"14\"\u003e\n\u003cdiv class=\"node__content\"\u003e\n\u003cdiv class=\"field field--name-field-content-options field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"field__item\"\u003e\n\u003cdiv class=\"paragraph paragraph--type--basic-text paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003cstrong\u003eSYNCOPE\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSyncope: when to worry about cardiac causes\u003c\/li\u003e\n\u003cli\u003eDiagnostic approach to the patient with recurrent syncope\u003c\/li\u003e\n\u003cli\u003eEvidence-based tools for risk-stratification in syncope\u003c\/li\u003e\n\u003cli\u003eOrthostatic syncope: does midodrine help?\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954442276962,"sku":"MED-AMB03626","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Harvard-Update-in-Hospital-Medicine-2024.webp?v=1779376855","url":"https:\/\/meducourse.com\/products\/harvard-update-in-hospital-medicine-2024","provider":"Meducourse","version":"1.0","type":"link"}